NanoViricides Inc. (NNVC)

[drkazmd65]

A lot of evidence from animal tests that the nanoviricide approach works, that it's safe, and that the viricides depend in no way on the particular biology of the host animal.

Agreed - absolutely on point.

I think the remaining logistical problems in front of Flucide are relatively non-risky - and that is just a matter of time and patience.

And since NNVC has enough money on hand to run at least one drug candidate into Clinical testing,.... the risk going forward with Flucide is relatively low.

Ebolacide2 is much more of a crapshoot (IMO) at this point. The Drs. have the advantage with Ebolacide that even their last version showed some limited usefulness in lab studies - not enough to 'cure' Ebola though - but enough to get some of the working parameters worked out for subsequent studies.

With the new ligand targets being utilized in Ebolacide2 - based on much more recent and conclusive testing as to what Ebola does to get into Human cells - I figure odds are that there is an improvement over what was seen in Ebola testing 5-6 years ago with the old targets. How much improvement? - That remains to be seen.

Ebolacide2 is the 'Wild Card' here,.... if it does show promise this Winter in USAMRIID's tests,.... NNVC just might have something - and should also relatively quickly have the means to produce it in large quantity.

Long-term - Flucide is still where this company makes its money though.